| Giselle Leibovitch, Phd, Llc | |
|
7274 Nw 68th Dr Parkland FL 33067-4730 | |
| (954) 817-1137 | |
| Not Available |
| Full Name | Giselle Leibovitch, Phd, Llc |
|---|---|
| Speciality | Psychologist |
| Location | 7274 Nw 68th Dr, Parkland, Florida |
| Authorized Official Name and Position | Giselle Leibovitch (OWNER/PSYCHOLOGIST) |
| Authorized Official Contact | 9548171137 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Giselle Leibovitch, Phd, Llc 7274 Nw 68th Dr Parkland FL 33067-4730 Ph: (954) 817-1137 | Giselle Leibovitch, Phd, Llc 7274 Nw 68th Dr Parkland FL 33067-4730 Ph: (954) 817-1137 |
| NPI Number | 1467044594 |
|---|---|
| Provider Enumeration Date | 02/10/2021 |
| Last Update Date | 02/10/2021 |
| Certification Date | 02/10/2021 |
| Medicare PECOS PAC ID | 6406255991 |
|---|---|
| Medicare Enrollment ID | O20210603002136 |
News Archive
In a study conducted by researchers at the Division of Gastroenterology, University of Michigan, Ann Arbor, and published in the current (August) issue of Gastrointestinal Endoscopy (GIE) by the American Society for Gastrointestinal Endoscopy (ASGE), 43% of the women who were asked their preference of a male or female endoscopist said female, while only 1.4% said male and the rest had no preference.
Titan Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
The Society of Interventional Radiology and Society for Vascular Surgery jointly will launch PRESERVE-the first large-scale, multispecialty prospective study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467044594 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Giselle Leibovitch |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1306950589 PECOS PAC ID: 8527137256 Enrollment ID: I20080520000770 |
News Archive
In a study conducted by researchers at the Division of Gastroenterology, University of Michigan, Ann Arbor, and published in the current (August) issue of Gastrointestinal Endoscopy (GIE) by the American Society for Gastrointestinal Endoscopy (ASGE), 43% of the women who were asked their preference of a male or female endoscopist said female, while only 1.4% said male and the rest had no preference.
Titan Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
The Society of Interventional Radiology and Society for Vascular Surgery jointly will launch PRESERVE-the first large-scale, multispecialty prospective study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment.
› Verified 6 days ago
News Archive
In a study conducted by researchers at the Division of Gastroenterology, University of Michigan, Ann Arbor, and published in the current (August) issue of Gastrointestinal Endoscopy (GIE) by the American Society for Gastrointestinal Endoscopy (ASGE), 43% of the women who were asked their preference of a male or female endoscopist said female, while only 1.4% said male and the rest had no preference.
Titan Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2010.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
The Society of Interventional Radiology and Society for Vascular Surgery jointly will launch PRESERVE-the first large-scale, multispecialty prospective study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment.
› Verified 6 days ago
Jennifer Ackrish, Psy.d. Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 11295 Nw 71st Ct, Parkland, FL 33076 Phone: 561-299-0483 Fax: 954-566-1186 | |
Teaching With Aba Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9131 Edgewater Bnd, Parkland, FL 33076 Phone: 954-495-6771 | |
Marla Berger, Lmhc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8800 Nw 72nd St, Parkland, FL 33067 Phone: 561-866-3056 | |
Gibbs Institute Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 9512 Exbury Ct, Parkland, FL 33076 Phone: 954-340-2402 | |
Sol Wellness And Psychiatry, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 12177 Nw 69th Ct, Parkland, FL 33076 Phone: 954-546-9050 | |
Gulenka Buergo 'llc' Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6310 Nw 63rd Way, Parkland, FL 33067 Phone: 305-776-0296 | |
Dy Behavior Therapy Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6331 Nw 95th Ln, Parkland, FL 33076 Phone: 917-494-5937 |